N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients

N-terminal pro atrial natriuretic peptide as a prognostic marker of cardiac resynchronization therapy recipients

Background: Although the dynamic changes of atrial natriuretic peptide (ANP) expressions in a failing heart are well-documented, the clinical implications of detailed measurements of each ANP molecular form processed from proANP remain unclear. Methods: Patients screening was conducted on patients w...

Full description

Bibliographic Details
Main Authors:	Nobuhiko Ueda, Naoya Kataoka, Yuichiro Miyazaki, Keiko Shimamoto, Akinori Wakamiya, Kenzaburo Nakajima, Tsukasa Kamakura, Mitsuru Wada, Kohei Ishibashi, Kenichiro Yamagata, Yuko Inoue, Koji Miyamoto, Satoshi Nagase, Takeshi Aiba, Koichiro Kinugawa, Naoto Minamino, Kengo Kusano
Format:	Article
Language:	English
Published:	Elsevier 2023-12-01
Series:	International Journal of Cardiology: Heart & Vasculature
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906723001136

Similar Items

Interference of cardiac implantable electronic devices and computed tomography imaging in the current era with a phantom model
by: Akihito Ideishi, et al.
Published: (2023-08-01)

Comparing the catheter delivery system and the stylet delivery system for ventricular lead placement in pacemaker implantation—The CATS delivery system randomized controlled trial
by: Kenichiro Yamagata, et al.
Published: (2019-06-01)

Differences in patient characteristics, clinical practice and outcomes of cardiac implantable electric device therapy between Japan and the USA: a cross-sectional study using data from nationally representative administrative databases
by: Takeshi Aiba, et al.
Published: (2023-01-01)

Prevalence and characteristics of the Brugada electrocardiogram pattern in patients with arrhythmogenic right ventricular cardiomyopathy
by: Nobuhiko Ueda, et al.
Published: (2021-10-01)

Complications Associated With Catheter Ablation in Patients With Atrial Fibrillation: A Report From the JROAD‐DPC Study
by: Yasuhiro Yokoyama, et al.
Published: (2021-06-01)

Long term prognosis in patients with pulmonary hypertension undergoing catheter ablation for supraventricular tachycardia
by: Hiroyuki Kamada, et al.
Published: (2021-08-01)

Real-world comparison of in-hospital complications after catheter ablation for atrial fibrillation between non-antivitamin K anticoagulants and warfarin: A propensity-matched analysis using nation-wide database
by: Koji Miyamoto, et al.
Published: (2023-02-01)

Feasibility of late gadolinium enhancement magnetic resonance imaging to detect ablation lesion gaps in patients undergoing cryoballoon ablation of paroxysmal atrial fibrillation
by: Tsuyoshi Mishima, et al.
Published: (2019-04-01)

Low‐Voltage Type 1 ECG Is Associated With Fatal Ventricular Tachyarrhythmia in Brugada Syndrome
by: Satoshi Nagase, et al.
Published: (2018-11-01)

Significance of Coronary Artery Spasm Diagnosis in Patients With Early Repolarization Syndrome
by: Tsukasa Kamakura, et al.
Published: (2018-02-01)

A Simple Predictive Marker in Cardiac Resynchronization Therapy Recipients: Prominent S-Wave in Right Precordial Leads
by: Naoya Kataoka, et al.
Published: (2021-08-01)

Impact of S-Wave Amplitude in Right Precordial Leads on Improvement in Mitral Regurgitation following Cardiac Resynchronization Therapy
by: Naoya Kataoka, et al.
Published: (2022-05-01)

Significance of Atrial and Brain Natriuretic Peptide Measurements in Fetuses With Heart Failure
by: Takekazu Miyoshi, et al.
Published: (2021-03-01)

Frequent His‐Purkinje discharges with longitudinal dissociation in a case with multiple premature ventricular contractions suppressed by co‐treatment with verapamil and quinidine
by: Keisuke Suzuki, et al.
Published: (2022-06-01)

A case of antidromic atrioventricular reciprocating tachycardia via the atriofascicular pathway with suspected minor manifest fusion during ventricular pacing
by: Hiroyuki Kamada, et al.
Published: (2022-08-01)

Local activation delay exacerbates local J-ST elevation in the epicardium: Electrophysiological substrate in Brugada syndrome
by: Naoya Kataoka, MD, PhD, et al.
Published: (2017-12-01)

Retracted: Effects of cardiac resynchronization therapy in patients with inotrope‐dependent class IV end‐stage heart failure
by: Ikutaro Nakajima, et al.
Published: (2013-12-01)

Cardiac Magnetic Resonance, Electromechanical Activation, Kidney Function, and Natriuretic Peptides in Cardiac Resynchronization Therapy Upgrades
by: Derek J. Bivona, et al.
Published: (2023-09-01)

Landiolol suppression of electrical storm of torsades de pointes in patients with congenital long-QT syndrome type 2 and myocardial ischemia
by: Ryota Kitajima, MD, et al.
Published: (2017-10-01)

Clinical Predictors of Pacing Device Implantation in Implantable Cardiac Monitor Recipients for Unexplained Syncope
by: Reina Tonegawa-Kuji, MD, PhD, et al.
Published: (2023-04-01)

T-wave oversensing during drug challenge test after subcutaneous implantable cardioverter-defibrillator implantation in a patient with Brugada syndrome
by: Tsukasa Kamakura, MD, PhD, et al.
Published: (2016-09-01)

Current status of cardiac resynchronization therapy device optimization in Japan
by: Kentaro Doi, et al.
Published: (2013-06-01)

Design of Mid‐Q Response: A prospective, randomized trial of adaptive cardiac resynchronization therapy in Asian patients
by: Kengo Kusano, et al.
Published: (2022-08-01)

Electrophysiological Remodeling in Heart Failure Dyssynchrony vs. Resynchronization
by: Takeshi Aiba, MD PhD, et al.
Published: (2010-01-01)

Differences in clinical characteristics and reported quality of life of men and women undergoing cardiac resynchronization therapy
by: Bruce L. Wilkoff, et al.
Published: (2020-10-01)

Undersensing of ventricular fibrillation by a biventricular implantable cardioverter‐defibrillator: What is the cause and the troubleshooting?
by: Kien Vo Le, et al.
Published: (2019-04-01)

Serum proteomic identification and validation of two novel atherosclerotic aortic aneurysm biomarkers, profilin 1 and complement factor D
by: Yusuke Murakami, et al.
Published: (2023-08-01)

Defibrillation lead placement using a transthoracic transatrial approach in a case without transvenous access due to lack of the right superior vena cava
by: Yosuke Otsuka, et al.
Published: (2015-06-01)

Evaluation of N-terminal pro B-type natriuretic peptide and echocardiographic parameters in congestive heart failure patients with pre- and post-cardiac resynchronization therapy
by: Amrendra Pandey, et al.
Published: (2020-01-01)

Geniposidic acid upregulates atrial natriuretic peptide secretion and lowers blood pressure in spontaneously hypertensive rats
by: Kozo Nakamura, et al.
Published: (2018-01-01)

Importance of exercise testing shortly after subcutaneous implantable cardioverter-defibrillator implantation in patients with Brugada syndrome – The first case of associated inappropriate shock in Japan
by: Kohei Ishibashi, MD, PhD, et al.
Published: (2017-04-01)

Combination of left ventricular reverse remodeling and brain natriuretic peptide level at one year after cardiac resynchronization therapy predicts long-term clinical outcome.
by: Tomas Roubicek, et al.
Published: (2019-01-01)

From local resynchronization to global pattern recovery in the zebrafish segmentation clock
by: Koichiro Uriu, et al.
Published: (2021-02-01)

Drastic Cardiac Reverse Remodeling Following Catheter Ablation in Patients with Atrial Fibrillation and Heart Failure
by: Takahisa Koi, et al.
Published: (2021-05-01)

Cardiac resynchronization therapy
by: Seth Worley, et al.
Published: (2018-10-01)

Cardiac resynchronization therapy
by: Seth Worley, et al.
Published: (2018-10-01)

Cardiac resynchronization therapy
by: Seth Worley, et al.
Published: (2018-10-01)

Innovative Cardiac Resynchronization
by: Zaki Akhtar, MBBS, et al.
Published: (2021-04-01)

Molecular ratio of mature B‐type natriuretic peptide in acute heart failure: an indicator for ventricular contractile recovery
by: Akihisa Kimura, et al.
Published: (2021-12-01)

NRSF/REST-Mediated Epigenomic Regulation in the Heart: Transcriptional Control of Natriuretic Peptides and Beyond
by: Hideaki Inazumi, et al.
Published: (2022-08-01)